Stephen Friend is Chairman of Sage Bionetworks, President and Founder of the charity “4YouandMe” and a visiting Professor of Connected Medicine at the University of Oxford.
His breakthrough approaches from discovery of the first cancer susceptibility genes in the 1980s at Harvard and MIT, to prototyping how knowns can be used to query unknowns at the start-up he launched (Rosetta Inpharmatics), to his time as a SVP at Merck and Co Inc. leading the Oncology efforts, to co-founding and leading the charity Sage Bionetworks that enables collaboration between researchers and participants, to The Resilience Project in 2014, through to his work at Apple 2015-2017 as a member of the Health Special Projects Team in building out the “ResearchKit” Apps, all have at their centre - a desire to change how we work and why we do what we do in preventing disease.
Stephen has previously held faculty positions at Harvard Medical School, Massachusetts General Hospital, University of Washington School of Medicine, and the Icahn School of Medicine. He received his Bachelor of Arts in philosophy, his PhD in biochemistry and his M.D. from Indiana University.